Published in Blood Weekly, July 9th, 2009
"Fluorodeoxyglucose-positron emission tomography (FDG-PET) is used to detect, stage, and restage solid tumors, including lymphomas and Richter trans formation. However its role in the management of liquid tumors and specifically in extramedullary AML has not been assessed. We present a case of a 64-year-old man who was diagnosed with AML and subsequently had recurrent...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.